1.24
price up icon6.90%   0.08
after-market After Hours: 1.27 0.03 +2.42%
loading

Palisade Bio Inc Stock (PALI) Forecast

The Palisade Bio Inc (PALI) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $69.13, representing a +5,475% increase from the current price of $1.24. The highest analyst price target is $69.11, and the lowest is $69.15.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month PALI Price Target
Average 53.89 (+4,246% Upside)
loading

Is Palisade Bio Inc (PALI) A Buy Now?

Oscillators
Name Value Action
RSI(14) 73.04 Sell
STOCH(9,6) 80.54 Sell
STOCHRSI(14) 78.49 Neutral
MACD(12,26) 0.1135 Buy
ADX(14) 32.64 Buy
William %R -23.53 Neutral
CCI(14) 190.77 Buy
Buy: 3 Sell: 2 Neutral: 2
Summary: Buy
Moving Averages
Period Simple Exponential
MA10
0.9534
Buy
1.0115
Buy
MA20
0.8448
Buy
0.9024
Buy
MA50
0.7614
Buy
0.817
Buy
MA100
0.7594
Buy
0.9418
Buy
MA200
1.4129
Sell
1.635
Sell
Buy: 8 Sell: 2 Neutral: 0
Summary: Buy
According to our latest analysis, PALI could be considered a Strong Buy, with 17 technical analysis indicators signaling 11 Buy signals, 4 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on PALI, as trading bullish markets is always a lot easier
  1. RSI (Relative Strength Index): The RSI(14) value of 73.04 indicates that PALI is overbought. This suggests that PALI price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
  2. STOCH (Stochastic Oscillator): The STOCH value of 80.54 indicates that PALI is oversold. This means that PALI price is at or near the highest level over a specified lookback period.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 78.49 indicates that PALI is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 32.64 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 190.77 indicates that PALI is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.

Long-term PALI price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Palisade Bio Inc financial reports and earnings history, Palisade Bio Inc (PALI) stock could reach $59.52 by 2030, $599.52 by 2040 and $875.57 by 2050. See the projected annual prices until 2050 of the Palisade Bio Inc stock below:

  • Palisade Bio Inc (PALI) is expected to reach an average price of $293.97 in 2035, with a high prediction of $302.35 and a low estimate of $294.12. This indicates an $23,607% rise from the last recorded price of $1.24.
  • Palisade Bio Inc (PALI) stock is projected to chart a bullish course in 2040, with an average price target of $607.52, representing an $48,894% surge from its current level. The forecast ranges from a conservative $30.66 to a sky-high $599.52.
  • Our analysts predict Palisade Bio Inc (PALI) to jump 30,351% by 2045, soaring from $377.69 to an average price of $377.60, potentially reaching $391.64. While $377.69 is the low estimate, the potential upside is significant.
  • Palisade Bio Inc (PALI) stock is expected to climb by 2050, reaching an average of $864.43, a $69,612% jump from its current level. However, a wide range of estimates exists, with high and low targets of $875.57 and $870.93, respectively, highlighting the market's uncertainty.

Palisade Bio Inc Stock (PALI) Year by Year Forecast

Palisade Bio Inc Stock (PALI) Price Forecast for 2025

Palisade Bio Inc Stock (PALI) is expected to reach an average price of $56.47 in 2025, with a high prediction of $69.66 and a low estimate of $43.28. This indicates an +4,454% rise from the last recorded price of $1.24.
Month Average Low High Change from today's price
August, 2025 $69.78 $69.15 $69.11 +5,527%
September, 2025 $67.15 $67.24 $67.86 +5,315%
October, 2025 $64.60 $66.31 $66.43 +5,110%
November, 2025 $63.18 $63.21 $63.29 +4,995%
December, 2025 $59.59 $59.63 $62.48 +4,706%

Palisade Bio Inc Stock (PALI) Price Forecast for 2026

The predicted value for Palisade Bio Inc (PALI) in 2026 is set at an average of $41.61. Estimates vary from a peak of $58.67 to a trough of $24.55, indicating an +3,256% surge from the present price of $1.24.
Month Average Low High Change from today's price
January, 2026 $56.83 $57.08 $58.67 +4,483%
February, 2026 $54.15 $54.28 $55.90 +4,267%
March, 2026 $49.95 $51.91 $53.40 +3,928%
April, 2026 $48.32 $48.38 $50.27 +3,797%
May, 2026 $45.77 $45.82 $47.51 +3,591%
June, 2026 $42.52 $42.65 $44.92 +3,329%
July, 2026 $38.46 $38.66 $41.82 +3,002%
August, 2026 $37.27 $37.26 $37.72 +2,905%
September, 2026 $33.72 $33.73 $36.53 +2,619%
October, 2026 $30.95 $30.97 $32.99 +2,396%
November, 2026 $28.09 $28.14 $30.12 +2,165%
December, 2026 $24.52 $24.55 $27.37 +1,877%

Palisade Bio Inc Stock (PALI) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Palisade Bio Inc (PALI) is $72.27, with a high forecast of $143.49 and a low forecast of $1.0431. This indicates an +5,728% increase from the last price of $1.24.
Month Average Low High Change from today's price
January, 2027 $21.70 $21.72 $23.71 +1,650%
February, 2027 $18.93 $18.94 $20.98 +1,427%
March, 2027 $15.50 $15.52 $17.42 +1,150%
April, 2027 $12.71 $12.71 $14.76 +925.17%
May, 2027 $6.1179 $6.4179 $11.97 +393.38%
June, 2027 $115.84 $1.0431 $107.84 +9,242%
July, 2027 $103.67 $107.17 $104.51 +8,261%
August, 2027 $102.00 $100.34 $98.92 +8,126%
September, 2027 $90.41 $97.41 $101.67 +7,191%
October, 2027 $106.24 $93.50 $87.74 +8,468%
November, 2027 $121.07 $113.83 $112.49 +9,664%
December, 2027 $156.24 $135.66 $143.49 +12,500%

Palisade Bio Inc Stock (PALI) Price Forecast for 2028

In 2028, Palisade Bio Inc (PALI) is projected to reach an average price of $143.16, with a high projection of $154.20 and a low estimate of $132.11. This indicates an +11,445% rise from the last price of $1.24.
Month Average Low High Change from today's price
January, 2028 $152.82 $152.65 $149.07 +12,224%
February, 2028 $151.40 $153.27 $151.57 +12,110%
March, 2028 $138.56 $138.56 $142.23 +11,074%
April, 2028 $145.89 $142.64 $141.09 +11,666%
May, 2028 $151.64 $152.56 $154.20 +12,129%
June, 2028 $149.72 $149.74 $147.57 +11,974%
July, 2028 $142.97 $144.96 $148.95 +11,430%
August, 2028 $150.38 $143.50 $146.88 +12,027%
September, 2028 $146.31 $146.96 $148.23 +11,699%
October, 2028 $143.08 $143.54 $143.75 +11,438%
November, 2028 $136.67 $136.81 $141.17 +10,922%
December, 2028 $131.39 $132.11 $135.13 +10,496%

Palisade Bio Inc Stock (PALI) Price Forecast for 2029

The 2029 price forecast for Palisade Bio Inc Stock (PALI) is $95.10 on average, with a high prediction of $129.17 and a low estimate of $61.04. This represents an +7,569% increase from the previous price of $1.24.
Month Average Low High Change from today's price
January, 2029 $123.00 $126.46 $129.17 +9,819%
February, 2029 $120.29 $120.42 $122.41 +9,601%
March, 2029 $114.55 $114.65 $117.56 +9,138%
April, 2029 $109.17 $109.26 $112.86 +8,704%
May, 2029 $102.20 $102.27 $107.59 +8,142%
June, 2029 $96.84 $96.97 $100.73 +7,710%
July, 2029 $91.37 $91.47 $95.38 +7,269%
August, 2029 $83.93 $84.03 $89.70 +6,668%
September, 2029 $77.75 $77.80 $82.07 +6,170%
October, 2029 $72.24 $72.32 $76.33 +5,726%
November, 2029 $66.70 $66.72 $70.83 +5,279%
December, 2029 $60.96 $61.04 $65.25 +4,816%

Palisade Bio Inc Stock (PALI) Price Forecast for 2030

Palisade Bio Inc Stock (PALI) is expected to reach an average price of $119.60 in 2030, with a high forecast of $230.76 and a low forecast of $8.4462. This signifies an +9,545% surge from the last price of $1.24.
Month Average Low High Change from today's price
January, 2030 $53.89 $53.99 $59.52 +4,246%
February, 2030 $48.20 $48.23 $52.45 +3,787%
March, 2030 $42.62 $42.63 $46.78 +3,337%
April, 2030 $36.88 $36.95 $41.18 +2,875%
May, 2030 $30.00 $30.01 $35.46 +2,319%
June, 2030 $24.35 $24.37 $28.55 +1,864%
July, 2030 $11.59 $12.98 $22.89 +834.76%
August, 2030 $239.63 $8.4462 $230.76 +19,225%
September, 2030 $208.13 $226.63 $226.01 +16,685%
October, 2030 $225.00 $219.00 $217.50 +18,045%
November, 2030 $196.49 $206.49 $200.75 +15,746%
December, 2030 $213.99 $206.57 $212.49 +17,157%
$23.09
price down icon 1.32%
$37.06
price up icon 1.06%
$101.75
price down icon 2.12%
$27.45
price down icon 4.26%
$112.79
price down icon 2.19%
biotechnology ONC
$294.51
price up icon 1.04%
Cap:     |  Volume (24h):